
Korean approval imminent for Ocrevus SC injection for multiple sclerosis
Ocrevus (ocrelizumab), a high-potency treatment for multiple sclerosis, is evolving from intravenous (IV) to subcutaneous (SC) injection, improving both treatment efficiency and patient convenience. The Ocrevus SC formulation, which can replace two to …